Integumen receives orders from trio of global firms

Josh White Sharecast | 19 Jun, 2017 14:31 | | |




17:18 18/08/17
  • 38,416.51
  • -0.21%-79.92
  • Max: 38,497.98
  • Min: 38,155.44
  • Volume: 0
  • MM 200 : n/a
17:25 18/08/17

Human integumentary system-focussed personal healthcare company Integumen announced on Monday that it had received orders from La Prairie, Merck & Co., and Galderma.

The AIM-traded firm said it had first received orders from Swiss-based beauty company La Prairie, for Integumen to conduct efficacy trials using its ‘Labskin’ product as the platform, which would test certain materials in La Prairie's range of products.

Its board described Labskin as a “three-dimensional human skin equivalent” (HSE) model that resembled the discrete biological layers found in human skin.

Since the EU ban on testing of cosmetics on animals, the company believed it was “ideally positioned” to take advantage of the fact that HSEs were being increasingly used by developers operating in the dermatology space, such as La Prairie.

The second order, from international developer, manufacturer and distributor of pharmaceuticals Merck, was an evaluation order with Integumen - also for the company's Labskin HSE model.

Its third order announced on Monday was from dermatological treatment specialist Galderma, a subsidiary of Nestlé.

Galderma also ordered Labskin for the testing of materials and formulations in their headquarters in Lausanne, Switzerland.

“We are delighted to receive these orders from such reputable blue chip clients,” said Integumen CEO Declan Service.

“With an ever-increasing focus on the human microbiome, Labskin's advantage of being able to host bacteria in a similar environment to that of human skin is proving to be an attractive option for companies focussed on R&D in skincare.”

Service said that, while relatively small in revenue terms, the three orders both demonstrated the company’s ability to commercialise its products and technologies, and its ability to build relationships with established companies.

“In addition, we have secured our first order for Labskin under the three-year OEM supply agreement we signed with our partner in Germany, all of which is testament to the hard work our sales and marketing team continues to do.”

More news

19 Aug US close: Stocks end lower despite Bannon departure

Wall Street slipped slight lower heading into the weekend as traders tried to figure out the implications of recent events on Capitol Hill and weighed the unexpected departure of White House chief strategist Steven Bannon.

18 Aug Europe close: Stocks edge slightly higher at the end of the session

Stocks pared early losses as traders digested a terrorist attack on Barcelona overnight and monitored the news-flow coming from the White House.

18 Aug Weeky review

The FTSE 100 finished the week almost flat, up 14.02 points or 0.19%, at 7,323.98.

18 Aug London close: Risk aversion grips FTSE, stocks lower on Trump and Barcelona attacks

London's FTSE 100 index fell below a key technical level as Friday's session wore on, with travel stocks leading the retreat after the terror attacks in Barcelona and the large cabal of overseas focused companies hit by the dollar's weakness amid renewed concerns about the US Presidency.

18 Aug BowLeven appoints new director

AIM-listed oil and gas group, BowLeven announced on Friday that Matt McDonald would be appointed to the firm's board as non-executive director with immediate effect.

18 Aug Week ahead: Not everything that happens at Jackson Hole stays there

In the coming week, the spotlight will be on the Federal Reserve bank of Kansas City's Symposium in Jackson Hole, Wyoming.

18 Aug Acacia remains a 'buy' for HSBC but target price slashed

HSBC cut its target price for Acacia Mining by 47% but kept its 'buy' recommendation in place as the months-long spat with the Tanzanian government still hangs over the company.

18 Aug US open: Stocks flat heading into the weekend, political ruckus weighs

Wall Street is essentially flat heading into the weekend after the head of the University of Michigan's consumer confidence survey said recent events in Charlottesville were likely to take their toll on sentiment.

18 Aug FTSE 250 movers: Hikma still looking ill; Kaz Minerals buffs up

Hikma Pharmaceuticals shares continued their downward spiral as HSBC slashed their target price, telling clients its first half numbers contained lower guidance for generics and a tougher outlook for injectables and branded drugs.

18 Aug Calpine agrees to be acquired for $5.6bn in cash

Shares of Calpine Corporation surged after news broke that the American power generation company had agreed to be acquired by a consortium led by Energy Capital Partners.